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Abstract The general transcription factor TFIID comprises the TATA-box-binding protein (TBP) 
and approximately 14 TBP-associated factors (TAFs). Here we find, unexpectedly, that 
undifferentiated human embryonic stem cells (hESCs) contain only six TAFs (TAFs 2, 3, 5, 6, 7 and 
11), whereas following differentiation all TAFs are expressed. Directed and global chromatin 
immunoprecipitation analyses reveal an unprecedented promoter occupancy pattern: most active 
genes are bound by only TAFs 3 and 5 along with TBP, whereas the remaining active genes are 
bound by TBP and all six hESC TAFs. Consistent with these results, hESCs contain a previously 
undescribed complex comprising TAFs 2, 6, 7, 11 and TBP. Altering the composition of hESC TAFs, 
either by depleting TAFs that are present or ectopically expressing TAFs that are absent, results in 
misregulated expression of pluripotency genes and induction of differentiation. Thus, the selective 
expression and use of TAFs underlies the ability of hESCs to self-renew.
DOI: 10.7554/eLife.00068.001
Introduction
The specification of tissues and organs in development depends upon the spatially and temporally 
accurate execution of gene expression programs, much of which is regulated at the level of transcrip-
tion. The factors involved in the accurate transcription of eukaryotic structural genes by RNA polymer-
ase II can be classified into two groups. First, general (or basic) transcription factors (GTFs) are 
necessary and can be sufficient for accurate transcription initiation in vitro (for review, see Thomas and 
Chiang, 2006). These basic factors include RNA polymerase II itself and at least six GTFs: TFIID, TFIIA, 
TFIIB, TFIIE, TFIIF and TFIIH. The GTFs assemble on the core promoter in an ordered fashion to form 
a pre-initiation complex (PIC).
Transcriptional activity is greatly stimulated by the second class of factors, promoter-specific activa-
tor proteins (activators). In general, activators are sequence-specific DNA-binding proteins whose rec-
ognition sites are typically present upstream of the core promoter. Activators work in large part by 
increasing PIC formation but can also act through other mechanisms, such as accelerating the rate of 
transcriptional elongation, promoting multiple rounds of transcription and directing chromatin modifi-
cations (reviewed in Green, 2005; Fuda et al., 2009; Weake and Workman, 2010).
A long-held view of transcription activation is that specificity arises from the differential expression 
and activity of activators, which function through the common basic transcription machinery. However, 
it is now clear that the differential expression and use of basic transcription factors can also contribute 
to eukaryotic gene regulation (reviewed in Davidson, 2003; Hochheimer and Tjian, 2003). This notion 
is most dramatically illustrated by a variety of studies focused on the GTF TFIID, a multi-subunit 
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complex composed of the TATA-box-binding protein (TBP) and a set of ∼14 TBP-associated factors 
(TAFs).
One of the earliest clues about the differential function of TFIID came from studies in yeast demonstrat-
ing distinct classes of protein-coding genes that differ by their dependence on and recruitment of TAFs 
(Kuras et al., 2000; Li et al., 2000). Subsequently, similar classes of TAF-dependent and -independent 
genes were identified in mammalian cells (Raha et al., 2005; Tokusumi et al., 2007). Consistent with 
the existence of TAF-independent promoters, more recent studies have found that TAFs are depleted 
upon terminal differentiation of muscle (Deato and Tjian, 2007; Deato et al., 2008) and liver 
(D’Alessio et al., 2011). TFIID diversity is also promoted by tissue-specific variants of TAFs as well as 
TBP derivatives referred to as TBP-related factors (reviewed in D’Alessio et al., 2009; Müller et al., 
2010).
Human embryonic stem cells (hESCs) are a good example of a specialized cell type that is regulated 
by a unique transcriptional network. Two characteristic properties of hESCs, pluripotency, a capacity 
to differentiate into all fetal and adult cell lineages, and the ability to undergo symmetrical self-renewing 
divisions, are largely controlled at the transcriptional level (reviewed in Chen and Daley, 2008). In 
undifferentiated hESCs, pluripotency genes such as OCT4 (also called POU5F1), NANOG and SOX2 
are expressed, whereas genes involved in differentiation are transcriptionally inactive (reviewed in Sun 
et al., 2006; Pan and Thomson, 2007). Decreased expression of pluripotency genes induces differen-
tiation (Niwa et al., 2000), and thus proper transcriptional regulation is essential for self-renewal of 
undifferentiated hESCs.
Despite intense efforts to identify hESC-specific activators involved in the transcriptional regulatory 
network of pluripotency, there has been relatively little analysis of GTFs in general and TFIID in particu-
lar. Here we find that both the composition and promoter occupancy patterns of hESC TAFs are highly 
unusual. We go on to show that this selective expression and use of TAFs establishes a transcriptional 
program required for hESC self-renewal.
eLife digest Embryonic stem cells have two characteristic properties: they are able to 
differentiate into any type of cell, a property known as pluripotency, and they are able to replicate 
themselves indefinitely to produce an endless supply of new stem cells. Different genes code for 
the various proteins associated with these two properties, and understanding the behaviour and 
properties of stem cells in detail is a major challenge in developmental biology. In human embryonic 
stem cells that have not yet differentiated, the genes that code for the transcription factors 
involved in the self-renewal process are expressed, whereas the genes associated with 
differentiation are not active. However, if the expression of the genes for self-renewal is reduced, 
the process of differentiation will begin, and the embryonic stem cells will be able to produce any 
one of the 200 or so different types of cell found in the human body.
All of this activity is orchestrated by proteins that oversee the transcription of specific regions of 
DNA into messenger RNA. Transcription is the first step in the process by which genes are expressed 
as proteins, and it cannot start until the relevant transcription factor binds to a stretch of DNA near 
the gene called the promoter. These transcription factors are complex structures that contain a 
central protein called TBP, which binds to the promoter, and 14 or so other proteins called TAFs.
Maston et al. now report that the transcription machinery that regulates gene expression and 
self-renewal in human embryonic stem cells is different from that found in other types of cells, 
including embryonic stem cells taken from mice. In particular, they found that undifferentiated 
human embryonic stem cells contain only 6 of the 14 TAFs observed in other cells, although all 14 
are present after differentiation. Moreover, for many active genes the transcription factors 
contained only two of these TAFs. There was also evidence for a new complex that contained the 
other four TAFs plus TBP.
Maston et al. also demonstrated that the removal of just one of the six TAFs, or the addition of 
just one extra TAF, caused the process of differentiation to begin. This shows, they argue, that the 
unusual transcription machinery they have discovered is essential for the proper workings of human 
embryonic stem cells.
DOI: 10.7554/eLife.00068.002
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Results
Undifferentiated hESCs express only a subset of TFIID TAFs
In a search of published expression datasets (Abeyta et al., 2004), we found that several TAFs of 
the canonical TFIID complex were apparently not expressed in hESCs. To investigate this possibil-
ity, we analyzed expression of 13 TAFs by immunoblotting lysates from H9 cells, a well-characterized 
hESC line. As a control, we also analyzed TAF expression in HeLa cells, which have been exten-
sively used to study TFIID composition and function. The immunoblot of Figure 1A shows, as 
expected, that all 13 TAFs were expressed in HeLa cells. By contrast, hESCs clearly expressed TAFs 2, 
3, 5, 6, 7 and 11, whereas expression of TAFs 1, 4, 8, 9, 10, 12, and 13 was undetectable. 
Interestingly, TAF6 is expressed in both cell types, but the isoform present in H9 cells is predominantly 
the short delta form, whereas in HeLa cells, the major TAF6 isoform is the larger, alpha/beta form. The 
specificity of each TAF antibody was confirmed by RNA interference (RNAi)-mediated knockdown 
(Figure 1—figure supplements 1 and 2). We observed a similar TAF expression pattern in a second 
hESC line, H1 cells (Figure 1—figure supplement 3). Quantitative RT-PCR (qRT-PCR) analysis compar-
ing TAF mRNA levels in HeLa and H9 cells correlated with the immunoblotting results (Figure 1B). 
Unlike the TAFs, all other GTFs analyzed were comparably expressed in HeLa and H9 cells (Figure 1C). 
Based upon these results we conclude that only six of the canonical TFIID TAFs are present in hESCs.
We next asked whether differentiation of hESCs results in a change in TAF composition. Toward this 
end, H9 cells were treated with retinoic acid to induce differentiation and TAF expression was analyzed 
by immunoblotting. Figure 1D shows, as expected, that following retinoic acid treatment, expression 
of the pluripotency factor OCT4 was lost and NES, a neuroectoderm marker, was induced. Significantly, 
TAFs 1, 4, 8, 9, 10, 12, and 13, which are not expressed in undifferentiated H9 cells, were induced fol-
lowing retinoic acid treatment. TAFs 2, 3, 5, 6, 7 and 11, which are expressed in undifferentiated H9 
cells, were also present at a relatively constant level following retinoic acid treatment.
hESCs have a non-canonical TBP-containing TAF complex
To investigate whether the six hESC TAFs were associated in a stable complex, H9 cell nuclear extract 
was fractionated by sucrose gradient sedimentation and individual fractions analyzed for TAFs 2, 3, 5, 
6, 7 and 11 by immunoblotting. The results of Figure 2A show that TAFs 2, 6, 7 and 11 co-sedimented 
with an apparent native molecular mass of ∼440 kDa. By contrast, TAFs 3 and 5 fractionated heterogen-
eously, and a substantial portion of both TAFs had an apparent molecular mass consistent with that of 
the free proteins (∼140 and ∼100 kDa, respectively). As expected, TBP, which is associated with mul-
tiple complexes involved in transcription by all three RNA polymerases, fractionated heterogeneously. 
Notably, however, a peak of TBP co-sedimented with TAFs 2, 6, 7 and 11.
To provide additional evidence for a stable, multi-subunit TAF complex, and to determine whether 
TBP was a component, we performed co-immunoprecipitation experiments. TBP was immunoprecipi-
tated from H9 cell nuclear extracts, and the immunoprecipitate was analyzed by immunoblotting for 
the six hESC TAFs. The results of Figure 2B show that TBP was stably associated with TAFs 2, 6, 7 and 
11 but not TAFs 3 and 5. Collectively, these results indicate that H9 cells contain a non-canonical TAF 
complex composed of TBP and TAFs 2, 6, 7 and 11 but not TAFs 3 and 5.
Two classes of active hESC genes based on TAF promoter occupancy
The results of the expression analysis and biochemical experiments implied that the PIC formed on the 
promoters of active genes in hESCs would have an atypical TAF composition. To investigate this issue, 
we performed a series of chromatin immunoprecipitation (ChIP) experiments. In the first set of experi-
ments we selected 10 transcriptionally active genes and performed ChIP analysis to monitor promoter 
occupancy by the six hESC TAFs. As a normalization standard, we also monitored occupancy of TBP 
and RNA polymerase II large subunit (POL2) on these 10 promoters. As expected, we found that TBP 
and POL2 were present at comparable levels at each of the 10 promoters (Figure 3A). However, the 
absolute level of TBP and POL2 bound to each promoter significantly varied among the 10 genes. 
Therefore, in this experiment and those presented below, TAF recruitment was normalized to the level 
of TBP occupancy. The ChIP results of Figure 3B revealed two groups of genes with distinct TAF pro-
moter occupancy patterns. The first group, which we refer to as class I genes, were bound by TAFs 3 
and 5 but not by TAFs 2, 6, 7 and 11, whereas the second group, class II genes, were bound by all six 
hESC TAFs.
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To support this conclusion, we also compared TAF occupancy in HeLa and H9 cells across seven 
class I genes that are transcriptionally active in both cell types (Figure 4A). As a control, we first ana-
lyzed a representative subset of TAFs that are expressed in HeLa but not H9 cells. The ChIP analysis of 
Figure 4B shows that TAFs 1, 8 and 9 were readily detected on the promoters of genes in HeLa cells 
but, as expected, not H9 cells. Next, we analyzed the six TAFs that are expressed in both HeLa and 
hESCs. Figure 4C shows that in both cell types TAFs 3 and 5 were recruited to the promoters of the 
seven genes. By contrast we found that TAFs 2, 6, 7 and 11 were bound to the promoters of the seven 
genes in HeLa but not in H9 cells (Figure 4C). These results indicate that on the same transcriptionally 
active gene the TAF composition is strikingly different in HeLa and H9 cells.
We next performed a series of RNAi experiments to determine the relationship between TAF 
occupancy and transcriptional activity. The qRT-PCR results of Figure 5A show that siRNA-mediated 
knockdown of TAFs 3 and 5 in H9 cells (Figure 5—figure supplement 1) greatly reduced expres-
sion of both class I and II genes. By contrast, siRNA-mediated knockdown of TAFs 2, 6, 7 and 11 
decreased expression of class II, but did not affect expression of class I genes (Figure 5B). 
Comparable results were obtained with a second, unrelated siRNA directed against each of the six 
TAFs (Figure 5—figure supplement 2). Collectively, these results establish a strong relationship 
between TAF occupancy and transcriptional activity in hESCs.
Figure 1. Undifferentiated hESCs express only a subset of TFIID TAFs. (A) Immunoblot analysis showing TAF levels 
in HeLa cells and H9 hESCs. β-actin (ACTB) was monitored as a loading control. (B) qRT-PCR analysis monitoring 
TAF expression in H9 cells relative to HeLa cells. A ratio of 1 (indicated by the red dotted line) indicates no 
difference in expression. Data are represented as mean ± SEM. (C) Immunoblot analysis showing levels of GTFs in 
HeLa cells and H9 hESCs. α-tubulin (TUBA) was monitored as a loading control. (D) Immunoblots showing TAF 
and TBP levels in H9 hESCs following induction of differentiation by retinoic acid treatment for 0, 3 or 6 days. OCT4 
and NES were monitored as controls.
DOI: 10.7554/eLife.00068.003
The following figure supplements are available for figure 1.
Figure supplement 1. Confirmation of specificity of TAF antibodies by RNAi-mediated knockdown in H9 hESCs. 
DOI: 10.7554/eLife.00068.004
Figure supplement 2. Confirmation of specificity of TAF antibodies by RNAi-mediated knockdown in HeLa cells. 
DOI: 10.7554/eLife.00068.005
Figure supplement 3. TAF expression levels in H1 hESCs. 
DOI: 10.7554/eLife.00068.006
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Global ChIP-chip analysis of TAF occupancy in hESCs
To confirm and extend the ChIP results, we performed global ChIP-chip analyses. In these experiments 
we monitored, in parallel, promoter occupancy of TAFs 3 and 5, TAFs 7 and 11 (as representative 
members of the TBP/TAF 2,6,7,11 complex), TBP and POL2. The overall results are summarized in 
Figure 6. We first defined a group of ∼3600 high-confidence actively transcribed genes based upon 
co-occupancy of both TBP and POL2 at the transcription start-site (Figure 6—figure supplements 1–3). 
The vast majority of active genes had promoter-bound TAF3 and TAF5 (Figure 6A). Significantly, a 
smaller fraction of active genes had promoter-bound TAF7 or TAF11, and there was substantial over-
lap between TAF7- and TAF11-bound genes (Figure 6B). As expected, the vast majority of genes 
bound by TAFs 7 and 11 were also bound by TAFs 3 and 5 (Figure 6C). Representative examples of 
promoter occupancy maps for two class I (SLC25A3, CCNB2) and class II (SFPQ, UCHL1) genes are 
shown in Figure 6D.
To validate the ChIP-chip results, we selected a representative set of 44 genes and performed 
directed ChIP experiments using promoter-specific primer pairs. These validation experiments, which 
are shown in Figure 7, confirmed the predicted TAF occupancy patterns for ≥85% of the genes tested. 
For example, consistent with the ChIP-chip results, there was no significant binding (i.e., no enrichment 
relative to the no antibody negative control) of TBP or TAFs 3, 5, 7 or 11 to a group of inactive pro-
moters predicted by the ChIP-chip analyses to not be bound by these factors (Figure 7A). Most import-
antly, Figure 7B shows that TAF7 occupancy validated at 24 of 27 predicted sites (88.9%), TAF11 
occupancy at 27 of 28 predicted sites (96.4%), TAF3 occupancy at 36 of 39 predicted sites (92.3%), and 
TAF5 occupancy at 39 of 39 predicted sites (100.0%).
Figure 7B also shows that the overlap between TAF7- and TAF11-bound genes was higher than 
that predicted by the ChIP-chip analyses. Specifically, the results show that TAF7 was present at 7 of 7 
predicted TAF11-only sites, and TAF11 was present at 5 of 6 predicted TAF7-only sites, indicating that 
TAF7 and 11 co-occupancy was 12 of 13 (92.3%).
Moreover, as expected, genes bound by TAFs 7 and 11 were also co-occupied by TAFs 2 and 6 
(Figure 7C). For example, of the 16 promoters analyzed that were bound by TAF7 and TAF11, 
TAF2 was present at 16 and TAF6 was present at 15 of these promoters. Collectively, the ChIP-chip 
analyses, in conjunction with the results described above, confirm the existence of two groups of 
genes in hESCs whose promoters are bound either only by TAFs 3 and 5 (class I genes) or by all six 
hESC TAFs (class II genes).
Finally, we analyzed the ChIP-chip dataset in relation to previous genome-wide studies in hESCs 
(Abeyta et al., 2004; Boyer et al., 2005; Guenther et al., 2007) for features that might distinguish 
class I and class II genes and found two statistically significant differences (Figure 6E,F; Table 1). First, 
the promoters of class I genes had greater histone H3 lysine 4 trimethylation (H3K4me3) than those of 
Figure 2. hESCs have a non-canonical TBP-containing TAF complex. (A) Sucrose gradient sedimentation. H9 cell 
nuclear extract was fractionated, and individual fractions were analyzed for TAFs by immunoblotting. Arrows 
indicate elution peaks of protein standards. (B) Co-immunoprecipitation analysis. Nuclear extracts from H9 cells 
were immunoprecipitated with an anti-TBP or control (anti-RAB2A) antibody and the immunoprecipitate was 
analyzed for TAFs and TBP by immunoblotting.
DOI: 10.7554/eLife.00068.007
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class II genes (Figure 6E). Second, the fraction of genes with alternative promoters (identified based 
upon UCSC Genome Browser annotations; see ‘Materials and methods’) was significantly higher for 
class II than for class I genes (Figure 6F). Representative examples of promoter occupancy maps for 
two class II genes with alternative promoters are shown in Figure 6G.
The composition of hESC TAFs is required for proper regulation of gene 
expression and maintenance of the undifferentiated state
Finally, we analyzed whether the unusual composition of TAFs was important for the characteristic ability 
of hESCs to maintain an undifferentiated state and self-renew. Figure 8A shows that shRNA-mediated 
knockdown of each of the six hESC TAFs (Figure 8—figure supplement 1) induced differentiation, as 
evidenced by a decreased percentage of alkaline phosphatase-positive colonies. To confirm this con-
clusion, we also tested whether knocking down hESC TAFs would induce differentiation by analyzing 
expression of a diverse set of differentiation markers: AFP (endoderm), CGB7 (trophoectoderm), IGF2 
(mesoderm), NES (ectoderm) and SOX1 (neuroectoderm). Figure 8B shows that depletion of each 
hESC TAF resulted in up-regulation, to varying extents, of these differentiation markers. Comparable 
results were obtained with a second, unrelated shRNA or siRNA directed against each of the six TAFs 
(Figure 8—figure supplements 2 and 3). Finally, the induction of differentiation following knockdown 
of hESC TAFs was also evidenced by decreased expression of the pluripotency genes NANOG (Figure 8C 
and Figure 8—figure supplement 4) and OCT4 (Figure 5 and Figure 5—figure supplement 2). Thus, 
the hESC TAFs are required to maintain the undifferentiated state.
In a reciprocal set of experiments, we altered TAF composition by ectopically expressing a TAF that 
is not normally present in hESCs. We found that ectopic expression of TAF1 (Figure 8D) resulted in 
differentiation, as evidenced by a decreased number of alkaline phosphatase-positive colonies (Figure 8E), 
the induction of differentiation markers (Figure 8F, left), and decreased expression of NANOG (Figure 8F, 
right). Interestingly, Figure 8G shows that ectopic TAF1 expression decreased expression of several 
class II genes, including as expected OCT4, whereas expression of class I genes was either unaffected 
or in some instances increased modestly. Ectopic expression of several other TAFs not present in 
Figure 3. Two classes of hESC genes based on TAF promoter occupancy. (A) Recruitment of TBP and POL2 to the 
promoters of 10 transcriptionally active genes (GAPDH, INTS6, MORF4L2, SLC25A3, TBP, TP53, FSCN1, OCT4, 
PCNA, SFPQ), each represented by a data point, were monitored by ChIP in H9 cells. For each gene, enrichment of 
TBP or POL2 binding to the promoter was normalized to a no antibody control and for non-specific recruitment at 
a control locus. (B) ChIP analysis monitoring TAF recruitment to the promoters of the 10 genes in H9 cells. TAF 
recruitment is specified relative to TBP recruitment (which was set to 1), after normalizing to a no antibody control 
and for non-specific recruitment to a control gene desert locus. Data are represented as mean ± SD.
DOI: 10.7554/eLife.00068.008
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hESCs also resulted in loss of expression of OCT4, a class II gene, but not ACTB, a class I gene (Figure 
8H). By contrast, ectopic expression of TBP or TAFs that are present in hESCs did not affect OCT4 
levels. To investigate the basis for the decreased OCT4 expression, we performed ChIP analysis. 
Figure 8I shows that, following ectopic expression of TAF1, TBP and POL2 were no longer recruited 
to the OCT4 promoter. Collectively, the results of Figure 8 show that altering the composition of hESC 
TAFs results in misregulation of gene expression and induction of differentiation.
Discussion
In this report we have shown that the general transcription machinery of hESCs is highly unusual in that 
approximately half of the canonical TFIID TAFs are not detectably expressed. The absence of TAFs was 
confirmed by multiple, independent experimental approaches including immunoblotting (Figure 1A 
and Figure 1—figure supplement 3), qRT-PCR (Figure 1B) and ChIP (Figure 4B). Previous studies 
have reported tissue-specific TAF variants and alterations in TAF expression (reviewed in D’Alessio 
et al., 2009; Müller et al., 2010), but the composition of hESC TAFs is unprecedented and is likely 
Figure 4. Comparison of TAF promoter occupancy on an identical set of transcriptionally active genes in HeLa and 
H9 cells. (A) Recruitment of TBP and POL2 to the promoters of seven class I genes (EEF1A1, FOS, GAPDH, 
SLC25A3, TBP, TLE4 and TP53) were monitored by ChIP in HeLa and H9 cells. Data were normalized as described 
in Figure 3A. (B) ChIP analysis monitoring recruitment of TAFs 1, 8 and 9 to the promoters of the seven class I 
genes in HeLa and H9 cells, as described in (A). Data are represented as mean ± SD. (C) ChIP analysis monitoring 
recruitment of TAFs 2, 3, 5, 6, 7 and 11 to the promoters of the seven class I genes in HeLa and H9 cells, as 
described in (A). Data are represented as mean ± SD.
DOI: 10.7554/eLife.00068.009
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highly specific, if not unique, to hESCs. For example, we find that mouse ESCs, which bear both 
similarities and differences to hESCs (Ginis et al., 2004; Wei et al., 2005; Schnerch et al., 2010), 
express all TFIID TAFs analyzed (Figure 9), consistent with the results of a recent study that focused on 
the role of TAF3 in mouse ESCs (Liu et al., 2011).
Following submission of our manuscript, the Encyclopedia of DNA Elements (ENCODE) consortium 
released an extensive set of genome-wide analyses including ChIP-Sequencing (ChIP-Seq) results for 
TAF1 in H1 hESCs (http://encodeproject.org/ENCODE/), implying that TAF1 is present in H1 cells. 
Notably, all but one of our experiments were performed in another hESC line, H9 cells. In the one 
experiment performed in H1 cells, we compared TAF levels in H1 and H9 cells by immunoblotting 
(Figure 1—figure supplement 3). The pattern of TAF expression in H1 and H9 cells was qualitatively 
similar but the experiment could not rule out the possibility that TAF1 was present at low levels in H1 
cells, which could explain the ENCODE ChIP-Seq results.
It is also possible that in the H9 cells used in our studies TAF1, as well as TAFs 4, 8, 9, 10, 12 and 13, are 
not entirely absent but rather present at low levels, which are below that we can detect in an immunoblot-
ting assay. However, if H9 cells do contain low levels of TAFs 1, 4, 8, 9, 10, 12 and 13 our biochemical 
experiments indicate that they are below that required to stably associate with TBP and the TAFs that are 
detectably present in H9 cells to form the much larger TFIID complex (Figure 2A). In addition, we could not 
detect significant binding of TAFs 1, 8 and 9 on the promoters of seven transcriptionally active genes 
in H9 cells in a ChIP assay, although binding was readily detected on the same promoters in HeLa cells 
(Figure 4B). Thus, our conclusion that H9 cells contain no (or very low levels of) TAFs 1, 4, 8, 9, 10, 12 and 13 
is based not only on expression data but also on biochemical results and promoter binding experiments.
Figure 5. A strong relationship between TAF occupancy and transcriptional activity in hESCs. (A) qRT-PCR analysis 
monitoring expression of class I and II genes in H9 TAF3 or TAF5 knockdown (KD) cells. Normalized Ct values were 
analyzed after subtracting the signal obtained with the control RN18S1 shRNA (see ‘Materials and methods’). Data 
are represented as mean ± SEM. (B) qRT-PCR analysis monitoring expression of class I and II genes in H9 TAF2, 6, 
7, or 11 KD cells. Data are represented as mean ± SEM.
DOI: 10.7554/eLife.00068.010
The following figure supplements are available for figure 5.
Figure supplement 1. siRNA-mediated knockdown efficiency of TAFs in H9 hESCs. 
DOI: 10.7554/eLife.00068.011
Figure supplement 2. Confirmation of TAF requirement for transcriptional activity using a second, unrelated siRNA. 
DOI: 10.7554/eLife.00068.012
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Figure 6. Global ChIP-chip analysis of TAF occupancy. (A) Venn diagram showing the overlap between TBP-, POL2-, TAF3- and TAF5-bound genes. 
(B) Venn diagram showing the overlap between TBP-, POL2-, TAF7- and TAF11-bound genes. (C) Venn diagram showing the overlap between TAF3- and 
TAF5-bound genes and TAF7- and TAF11-bound genes. (D) Representative maps showing TAF3, TAF5, TAF7, TAF11, TBP and POL2 occupancy at the 
promoters of class I (SLC25A3 and CCNB2) and class II (SFPQ and UCHL1) genes. (E) Differences between class I and II genes with respect to promoter 
H3K4me3. (F) Differences between class I and II genes with respect to average number of alternative promoters per ChIP-enriched site. 
(G) Representative promoter occupancy maps for two class II genes with alternative promoters, IFRD1 and CSF2RA.
DOI: 10.7554/eLife.00068.013
The following figure supplements are available for figure 6.
Figure supplement 1. Location of TBP, POL2 and TAF occupancy relative to the transcription start site. 
DOI: 10.7554/eLife.00068.014
Figure supplement 2. ChIP-chip peak overlap in independent replicates. 
DOI: 10.7554/eLife.00068.015
Figure supplement 3. Co-occupancy of TBP and POL2 with TAFs. 
DOI: 10.7554/eLife.00068.016
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Figure 7. Validation of ChIP-chip results by directed ChIP experiments using promoter-specific primer pairs. 
(A) ChIP analysis monitoring binding of TBP and TAFs 3, 5, 7 and 11 to a representative set of promoters that, based 
on ChIP-chip analyses, were predicted not to be bound by these factors. The results were normalized to a no 
Figure 7. Continued on next page
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antibody control (which was set to 1). Data are represented as mean ± SEM. For four genes (THOC1, CBWD3, RBM39 
and ZNF260), the inactive promoter (A2) was analyzed in (A), and the active promoter (A1) was analyzed in (B) and (C). 
(B) ChIP analysis monitoring binding of TAFs 3, 5, 7 and 11 to the promoters of a representative set of 47 genes 
predicted by the ChIP-chip analyses to be bound by some or all of the factors. Data are normalized to TBP. Cutoff for a 
‘positive’ is >0.4-fold enrichment vs TBP (red line). Data are represented as mean ± SEM. (C) ChIP analysis monitoring 
binding of TAF2 and TAF6 to 19 promoters that are bound by TAF7 and TAF11. Data are represented as mean ± SEM.
DOI: 10.7554/eLife.00068.017
Figure 7. Continued
A novel TBP-containing TAF complex in undifferentiated hESCs
The absence of seven of the conventional TFIID TAFs suggested that hESCs contain an alternative 
TBP-containing complex. Our ChIP and biochemical experiments confirmed this possibility and 
revealed a model in which a stable complex containing TBP and TAFs 2, 6, 7 and 11 is recruited to 
active class II genes, and TAFs 3 and 5 are recruited independently to all active genes (Figure 8J). 
Notably, this novel TBP-containing complex lacks TAF1, which in the canonical TFIID complex interacts 
directly with TBP (Chen et al., 1994), and TAF4, which is essential for assembly of Drosophila TFIID 
(Wright et al., 2006). However, consistent with the existence of a TBP/TAF 2,6,7,11 complex, previous 
studies have described interactions between TBP and TAF2 (Verrijzer et al., 1994), TAF6 (Weinzierl 
et al., 1993) and TAF11 (Lavigne et al., 1996), and between TAF7 and TAF11 (Lavigne et al., 1996).
Previous studies have shown that nine of the 14 TFIID TAFs contain a sequence motif homologous 
to histones, called the histone fold domain (HFD), which mediates protein–protein interactions 
(reviewed in Cler et al., 2009; Papai et al., 2011). These nine TAFs can form five specific heterodimers: 
TAF3–10, TAF6–9, TAF4–12, TAF8–10 and TAF11–13. Several of these heterodimers are thought to be 
important for the assembly and structure of TFIID. hESCs contain only three HFD-containing TAFs (3, 6 
and 11), which cannot form any of the five known heterodimers. This observation strongly suggests 
there are major differences in assembly and structure of TFIID and the TBP/TAF 2,6,7,11 complex.
An important question raised by our results is the basis by which TAFs are differentially recruited to 
class I or class II promoters. Studies in yeast have shown that differential recruitment of TAFs can be 
due to promoter-bound activators, core promoter elements, or both (Shen and Green, 1997; Li et al., 
2002). In this regard, TAF2 and TAF6 have been shown to interact with promoter sequence elements 
(reviewed in Maston et al., 2006), which may contribute to differential promoter recognition by the 
TBP/TAF 2,6,7,11 complex. In addition, TAF3 contains a PHD finger domain that can bind to the 
H3K4me3 chromatin mark (Vermeulen et al., 2007), which is enriched at class I promoters (Figure 6E).
Understanding the basis by which basic transcription factors are differentially recruited to promoters 
on a genome-wide scale appears to be a particularly challenging problem. For example, it is still not 
understood what distinguishes TAF-dependent and TAF-independent promoters in yeast (Kuras et al., 
2000; Li et al., 2000), why some basic transcription factors, such as mediator, are bound at only some 
promoters (Fan et al., 2006), or the basis by which chromatin-modifying complexes are selectively 
recruited to promoters (Ng et al., 2002).
Another question arising from our findings is whether there are functional differences that distin-
guish class I and class II genes. Gene ontology analysis did not reveal any functional category that was 
differentially enriched in either class I or class II genes (data not shown). For example, although several 
pluripotency factors including OCT4 (Figure 3B) and NANOG (Figure 10) are encoded by class II 
genes, we found other pluripotency factors, such as SOX2, DPPA4 and KLF4, that are encoded by class 
I genes (Figure 10). There was, however, a statistically significant increase in alternative promoters at 
class II genes (Figure 6F). Notably, alternative promoter use has been suggested to play a role in gen-
erating tissue-specific transcripts (Kimura et al., 2006; Kolle et al., 2011; Pal et al., 2011).
Our ChIP experiments show that genes that are broadly expressed, such as housekeeping genes, 
can be activated by diverse core promoter recognition complexes in different cell types (Figure 4C), 
revealing a remarkable plasticity of the transcription machinery. The core promoter sequence is identi-
cal in every cell, raising the possibility that in hESCs differences in activators or epigenetic signatures 
may be coordinated with the alterations in core promoter complexes. For example, in the myogenic 
program, core promoter recognition complex changes correlates with the presence of developmen-
tally regulated activators (Deato et al., 2008).
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Table 1. Statistical analysis of ChIP-chip data
Feature
All TBP +  
POL2 sites
Class I genes  
(p-value vs  
TBP + POL2)
Class II genes  
(p-value vs  
TBP + POL2)
p-value  
(Class I vs 
Class II)
Alternative promoters (average number) 0.717 0.686 (0.008) 0.934 (2.64 × 10−67) 1.73 × 10−58
Bidirectional promoters (percent) 23.961 25.315 (0.005) 28.186 (0.007) 0.110
Promoter occupancy (percent)
H3K4me3 91.482 89.214 (8.72 × 10−05) 82.721 (4.24 × 10−20) 1.16 × 10−13
OCT4 3.684 3.919 (0.728) 3.064 (1.000) 0.293
NANOG 12.438 13.448 (0.006) 13.725 (0.698) 0.861
SOX2 10.243 11.471 (9.64 × 10−05) 11.642 (0.474) 0.901
Promoter elements (percent)
TATA box 4.834 6.365 (5.15 × 10−15) 7.353 (0.012) 0.335
BRE 88.999 92.413 (6.27 × 10−24) 92.892 (0.001) 0.650
Initiator 99.608 99.928 (0.000) 100.000 (1.000) 0.402
MTE 0.679 0.611 (1.000) 0.735 (1.000) 0.626
DCE 99.843 99.964 (0.422) 99.877 (1.000) 0.402
DOI: 10.7554/eLife.00068.018
The selective expression and use of TAFs is required for hESC self-renewal
We have found that altering the composition of hESC TAFs, either by RNAi-mediated knockdown of 
TAFs that are present or ectopic expression of TAFs that are absent, results in loss of pluripotency gene 
expression and induction of differentiation. Thus, the unusual composition of TAFs described here 
is required for the ability of hESCs to properly regulate gene expression, maintain an undifferentiated 
state, and self-renew. This conclusion is reinforced by the finding that the TAFs that are absent from 
undifferentiated hESCs are expressed following differentiation (Figure 1D). The transcriptional induc-
tion of several differentiation markers, which are not normally expressed in hESCs, following knock-
down of an hESC TAF can be explained either by the dispensability of the TAF for transcription of the 
marker, or incomplete knockdown enabling transcription to occur at reduced TAF levels.
A characteristic feature of the switch of undifferentiated hESCs to the differentiated state is the loss 
of pluripotency gene expression. We have shown that ectopic expression of TAFs that are not present 
in undifferentiated hESCs results in transcriptional inactivation of pluripotency genes. Thus, the tran-
scriptional induction of TFIID TAFs that are absent from undifferentiated hESCs may be at least part of 
the mechanism by which pluripotency genes are silenced following differentiation.
As discussed above, previous studies have shown that terminal differentiation of muscle (Deato 
and Tjian, 2007) and liver (D’Alessio et al., 2011) is accompanied by loss of TFIID TAFs. These and 
other findings have prompted speculation that during differentiation the canonical TFIID complex 
becomes progressively specialized (reviewed in D’Alessio et al., 2009). However our results reveal a 
more complex model. Rather than starting from a complete, canonical TFIID and progressing to more 
restricted forms, undifferentiated hESCs start with a specialized, highly unique general transcription 
machinery, then switch to a period of complete TFIID before specialization of the transcription machin-
ery again in some terminal differentiation programs. Collectively, these findings suggest that altering 
the composition of the basic transcription machinery in general and TAFs specifically may be a particu-
larly powerful mechanism for developmental reprogramming.
Materials and methods
Cell lines and culture
H9 (WA09) and H1 (WA01) hESCs were obtained from the UMass Human Stem Cell Bank and Registry. 
Cell lines were cultured on irradiated mouse feeder cells using DMEM/F12 media supplemented with 
KnockOut SR (Invitrogen, Carlsbad, CA) and basic FGF (R&D Systems, Minneapolis, MN), and cultures 
were karyotyped every 10–15 passages. All hESCs used were between passages 40–65. hESCs for 
Genes and chromosomes
Maston et al. eLife 2012;1:e00068. DOI: 10.7554/eLife.00068 13 of 19
Research article
Figure 8. Continued on next page
Figure 8 The composition of hESC TAFs is required for maintenance of the undifferentiated state. (A) Percent 
of H9 TAF knockdown (KD) colonies staining with alkaline phosphatase. Data are represented as mean ± SD.  
(B) qRT-PCR analysis monitoring expression of differentiation markers (AFP, CGB7, IGF2, NES and SOX1) in H9 cells 
treated with a TAF siRNA. Values are relative to those obtained with a control luciferase siRNA, which was set to 1. 
Data are represented as mean ± SEM. (C) qRT-PCR analysis monitoring expression of NANOG in H9 cells treated 
with a TAF siRNA. Values are relative to those obtained with a control luciferase siRNA, which was set to 1. Data are 
represented as mean ± SEM. (D) qRT-PCR analysis monitoring TAF1 expression in H9 cells transfected with a 
plasmid expressing TAF1 or, as a control, empty vector. Expression of TAF1 was monitored 48 hr following 
transfection. TAF1 expression is specified relative to that obtained with the empty vector, which was set to 1. Data 
are represented as mean ± SEM. (E) Alkaline phosphatase staining of H9 colonies ectopically expressing TAF1 or, 
as a control, vector. Data are represented as mean ± SD. (F) qRT-PCR monitoring expression of differentiation 
markers (AFP, CGB7, IGF2, NES and SOX1) in H9 cells ectopically expressing TAF1. Values are relative to those 
obtained in H9 cells expressing vector, which was set to 1. Data are represented as mean ± SEM. (G) qRT-PCR 
monitoring expression of class I and II genes in H9 cells ectopically expressing TAF1. Data are represented as mean 
± SEM. (H) Immunoblot analysis showing OCT4 levels in H9 cells over-expressing TAFs, TBP or vector. (I) ChIP 
analysis monitoring recruitment of TBP, POL2 and TAF1 to the OCT4 promoter in H9 cells ectopically expressing 
TAF1 or vector. Data are represented as mean ± SD. (J) Schematic model. Some of the protein interactions shown 
are arbitrary.
DOI: 10.7554/eLife.00068.019
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Figure 8. Continued
ChIP experiments were harvested 5–6 days after passage to ensure high density, such that the mouse 
feeder cells represented less than ∼12% of the total material (similar to what has been used in previ-
ously published hESC ChIP experiments; Boyer et al., 2005). For Figure 1D, H9 cells were passaged 
using Accutase (STEMCELL Technologies, Vancouver, Canada) and plated without feeders in DMEM 
containing 10% FBS and 1 µM all-trans retinoic acid (Sigma, St. Louis, MO). For transfections, H9 cells 
were grown in mTesR1 media (STEMCELL Technologies) under feeder-free conditions on plates coated 
with Matrigel (BD Biosciences, San Jose, CA). HeLa cells were maintained in DMEM supplemented 
with 10% FCS at 37°C and 5% CO2. The mouse ESC line PGK12.1, provided by N. Brockdorff, was 
cultured as previously described (Penny et al., 1996).
Immunoblot analysis
Cells were trypsinized, pelleted, and washed twice in PBS. Nuclei were isolated by incubating the cell 
pellet in lysis buffer [10 mM Pipes-K+ pH 6.9, 0.2% NP-40, 5 mM KCl, 1.5 mM MgCl2, 2 µM ZnSO4, 5% 
glycerol, 2% PEG 2000, plus 1 mM PMSF; Complete Protease Inhibitor Cocktail (Roche, Basel, Switzerland) 
and phosphatase inhibitors (Sigma P2850 and P5726)] for 2 min on ice, and pelleted by centrifugation. 
Nuclei were resuspended in nuclear extract buffer (NEB1: 25 mM PIPES pH 6.9, 0.2% Tween 20, 0.4 M 
NaCl, 1.5 mM MgCl2, 2 µM ZnSO4, 5% glycerol, 2% PEG 2000, plus 1 mM PMSF; Complete Protease 
Inhibitor Cocktail and phosphatase inhibitors) for 10 min on ice, followed by centrifugation to remove 
nuclear debris. Protein content of the nuclear extracts was measured by BCA assay. Nuclear extracts 
were separated on either 8% or 12% SDS-PAGE gels. Blots were probed with primary antibodies (listed 
in Supplementary file 1A) overnight at 4°C, washed five times in TBP plus 0.1% Tween (TBST) and then 
incubated with the appropriate HRP-conjugated secondary antibody for 1 hr at room temperature. 
Membranes were washed five times in TBST and visualized on autoradiography film after incubating with 
ECL reagent (Supersignal West Pico or Supersignal West Femto; Thermo Scientific, Waltham, MA).
Quantitative RT-PCR
Total RNA was isolated using TRIzol (Invitrogen), then treated with DNase I (Promega, Fitchburg, WI) and 
repurified using RNeasy columns (Qiagen, Hilden, Germany). Reverse transcription was performed using 
the SuperScript II Reverse Transcription Kit (Invitrogen) with random oligo priming, followed by quantitative 
real-time PCR using Platinum SYBR Green qPCR SuperMix-UDG with Rox (Invitrogen) on either an ABI 
7500 or StepOne Plus Real-Time PCR System (Applied Biosystems, Carlsbad, CA). Primer sequences are 
listed in Supplementary file 1B. For all reactions, inputs were normalized and the Ct values of samples 
were analyzed after subtracting the signal obtained with the non-silencing shRNA (for RNAi) or no 
antibody (for ChIP) controls. For TAF knockdown experiments, human 18S rRNA (RN18S1) was used as 
the endogenous control, because its expression should not be affected by changes in TAF expression.
Sucrose gradient sedimentation
Sucrose gradient sedimentation analysis was performed as described (Tanese, 1997). Briefly, 10–40% 
gradients were formed by layering 500 µl NEB1 (see ‘Immunoblot analysis’) containing 10%, 20%, 30%, 
or 40% sucrose in a 11 × 34-mm centrifuge tube (Beckman, Brea, CA) and allowed to equilibrate at room 
temperature for 2 hr. Gradients were chilled, loaded with either 500 µg H9 nuclear extract (adjusted to a 
volume of 200 µl) or 200 µl molecular weight markers (Sigma MW-GF-1000), and centrifuged in a 
Beckman TLS-55 rotor at 50,000 rpm (214,000×g) for 12 hr. Twenty-three fractions of ∼90 µl were col-
lected. For the markers, 20 µl of each fraction was electrophoresed and Coomassie stained. For the H9 
gradient fractions, 25 µl of even-numbered fractions were analyzed by immunoblotting.
The following figure supplements are available for figure 8
Figure supplement 1. shRNA-mediated knockdown efficiency of TAFs in H9 hESCs. 
DOI: 10.7554/eLife.00068.020
Figure supplement 2. Validation of results presented in Figure 8A using a second, unrelated shRNA. 
DOI: 10.7554/eLife.00068.021
Figure supplement 3. Validation of results presented in Figure 8B using a second, unrelated siRNA. 
DOI: 10.7554/eLife.00068.022
Figure supplement 4. Validation of results presented in Figure 8C using a second, unrelated siRNA. 
DOI: 10.7554/eLife.00068.023
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Co-immunoprecipitation
H9 nuclear extract (600 µg) was incubated with 
6 µg of anti-TBP antibody (Santa Cruz, Santa 
Cruz, CA) at overnight at 4°C. Immune com-
plexes were captured on rabbit TrueBlot IP 
beads (eBioScience, San Diego, CA), washed 
three times in NEB1, and eluted by boiling 10 
min in 2× SDS sample buffer. IP material was 
then analyzed for the presence of TAFs by 
immuno blotting (see Supplementary file 1A), 
using the Rabbit IgG TrueBlot HRP-conjugated 
secondary antibody (eBioScience).
ChIP and ChIP-chip assays
Cells were dual-cross-linked with ethylene 
glycolbis[succinimidyl succinate] (EGS), and for-
maldehyde as described (Zeng et al., 2006). 
Chromatin shearing and ChIP experiments were 
then performed essentially as reported (Hart et al., 2007), with slight modifications. For each ChIP experi-
ment, 500 µg chromatin (based on BCA assay) was pre-cleared with BSA- and ytRNA-blocked protein G 
agarose beads (Millipore, Billerica, MA). The pre-cleared supernatant was then incubated with 5 µg of pri-
mary antibody (see Supplementary file 1A) at 4°C overnight. Immune complexes were precipitated with 
protein G-agarose beads, washed, eluted, and purified as described. ChIP products were analyzed by qRT-
PCR using pri mers listed in Supplementary file 1B. Real-time PCR results were analyzed using QBasePlus 
software (Biogazelle, Zwijnaarde, Belgium). Site-specific relative fold changes of ChIP-enriched samples 
were calculated by comparing the amplification threshold (Ct) value of a given ChIP sample at a specific 
target locus (promoter) with the amplification Ct of a no-antibody control at the same target locus being 
analyzed, and also with the same ChIP sample and no-antibody control sample Ct values at a non-recruiting 
control locus found in a gene desert on human chromosome 16 (primers ‘GDM’ in Supplementary file 1B).
For ChIP-chip, 200 ng of ChIP-enriched or no-antibody control chip DNA fragments were blunted using 
End-It DNA End-Repair Kit (Epicentre Biotechnologies, Madison, WI), then ligated to unidirectional linkers 
(annealed oligos oJW102: 5′-GCGGTGACCCGGGAGATCTGAATTC and oJW103: 5′-GAATTCCAGATC) 
using Fast-link DNA ligation kit (Epicentre Biotechnologies). Linker-adapted DNA was amplified for 18 
rounds using high-fidelity Pfu polymerase, then purified. DNA was labeled with either Cy5-dCTP (chip 
samples) or Cy3-dCTP (no antibody control) in a second PCR amplification of 18 rounds. The labeled DNAs 
were purified on QIAquick columns (Qiagen) and the incorporation was checked by spectrophotometry. 20 
pmol of each labeled DNA (chip and control) was combined and used to hybridize to a Human ChIP-chip 
3 × 720K RefSeq Promoter Array (Roche NimbleGen, Madison, WI) using a hybridization kit, sample track-
ing controls, wash buffer kit and array processing accessories from NimbleGen. Arrays were scanned on an 
Agilent Scanner at 5 µm resolution. Data were analyzed to identify peaks of binding using Nimblescan 
software (Roche NimbleGen) with default settings. Further analysis of ChIP data was conducted using 
ChipPeakAnno (Zhu et al., 2010). The list of sites were filtered to remove multiple peaks occurring in the 
same promoter, which resulted in a set of genes whose promoters are bound by each factor. The data 
discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus (Edgar et al., 2002) 
and are accessible through GEO Series accession number GSE39312 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE39312). Promoter maps shown in Figure 6 were generated using the UCSC 
Genome Browser (genome.ucsc.edu).
For alternative promoter analyses, our ChIP-chip datasets were compared with the AltEvents track on 
the UCSC Genome Browser to find the frequency of overlap between chip peaks and ‘AltPro’ annota-
tions. For comparison with H3K4me3, we used previously published data (Guenther et al., 2007) after 
converting that dataset to HG18 coordinates using Galaxy (Goecks et al., 2010). Statistical significance 
of differences in occurrence was determined using Fisher’s exact test.
RNA interference
For transient siRNA transfections, 30 pmol of siRNA duplexes (see Supplementary file 1C) was mixed 
with 5 µl Lipofectamine RNAiMAX and OptiMEM Reduced-Serum media (Invitrogen) in a total volume 
Figure 9. TAF expression in mouse ESCs. Immunoblot 
analysis monitoring TAF levels in PGK12.1 mouse ESCs 
and, as a control, HeLa cells. ACTB was monitored as a 
loading control. The results show that TAFs 1, 4, 8, 9, 10 
and 13, which are not expressed in hESCs, are 
expressed in mouse ESCs.
DOI: 10.7554/eLife.00068.024
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of 500 µl, incubated for 20 min, and added to 
H9 cells 1 day after plating in a six-well plate 
(i.e., at ∼25% confluency) along with 2.5 ml 
fresh media. After 48 hr, RNA was isolated or 
nuclear extract prepared. For stable shRNA 
knockdowns, H9 cells seeded in a six-well 
plate to 25% confluency were stably trans-
duced with 200-µl lentiviral particles expres-
sing shRNAs (obtained from Open Biosystems 
through the UMMS RNAi Core Facility; see 
Supplementary file 1C) in a total volume of 2 ml 
of mTesR1 media supplemented with 6 µg/ml 
polybrene. Media was replaced after over-
night incubation to remove the polybrene and 
viral particles.
Alkaline phosphatase staining
Alkaline phosphatase staining was performed 
using the Alkaline Phosphatase Staining Kit 
(Stemgent, Cambridge, MA). To assess differen-
tiation, 500 colonies were evaluated for AP staining and the percent positively stained was calculated. 
All assays were performed in triplicate.
Ectopic TAF expression
Full-length open reading frames of human TAF genes were PCR-amplified from HeLa cDNA and cloned 
in-frame into pECFP vector (Clontech Laboratories, Mountain View, CA). Junctions were sequenced to 
confirm the construction. For transfection, 2 µg plasmid was mixed with 6 µl FuGENE HD Transfection 
Reagent (Roche) and OptiMEM in a total volume of 100 µl, incubated for 15 min, and then added to H9 
cells in a six-well plate at 25% confluency. After 48 hr, RNA was isolated or nuclear extract prepared.
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